BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oft M. IL-10: master switch from tumor-promoting inflammation to antitumor immunity. Cancer Immunol Res. 2014;2:194-199. [PMID: 24778315 DOI: 10.1158/2326-6066.cir-13-0214] [Cited by in Crossref: 112] [Cited by in F6Publishing: 65] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee-Chang C, Rashidi A, Miska J, Zhang P, Pituch KC, Hou D, Xiao T, Fischietti M, Kang SJ, Appin CL, Horbinski C, Platanias LC, Lopez-Rosas A, Han Y, Balyasnikova IV, Lesniak MS. Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma. Cancer Immunol Res 2019;7:1928-43. [PMID: 31530559 DOI: 10.1158/2326-6066.CIR-19-0240] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 16.5] [Reference Citation Analysis]
2 Merhi M, Raza A, Inchakalody VP, Nashwan AJJ, Allahverdi N, Krishnankutty R, Uddin S, Zar Gul AR, Al Homsi MU, Dermime S. Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report. Front Immunol 2018;9:1769. [PMID: 30108590 DOI: 10.3389/fimmu.2018.01769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Arreola R, Quintero-Fabián S, López-Roa RI, Flores-Gutiérrez EO, Reyes-Grajeda JP, Carrera-Quintanar L, Ortuño-Sahagún D. Immunomodulation and anti-inflammatory effects of garlic compounds. J Immunol Res 2015;2015:401630. [PMID: 25961060 DOI: 10.1155/2015/401630] [Cited by in Crossref: 95] [Cited by in F6Publishing: 60] [Article Influence: 15.8] [Reference Citation Analysis]
4 Chuang MH, Chang JT, Hsu LJ, Jan MS, Lu FJ. Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular Carcinoma. Integr Cancer Ther 2017;16:516-25. [PMID: 27698264 DOI: 10.1177/1534735416664173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Lee YS, Lee CH, Bae JT, Nam KT, Moon DB, Hwang OK, Choi JS, Kim TH, Jun HO, Jung YS, Hwang DY, Han SB, Yoon DY, Hong JT. Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition. J Exp Clin Cancer Res 2018;37:293. [PMID: 30486830 DOI: 10.1186/s13046-018-0943-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
6 Jarosz-Biej M, Kamińska N, Matuszczak S, Cichoń T, Pamuła-Piłat J, Czapla J, Smolarczyk R, Skwarzyńska D, Kulik K, Szala S. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma. PLoS One 2018;13:e0191012. [PMID: 29320562 DOI: 10.1371/journal.pone.0191012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 14.3] [Reference Citation Analysis]
7 Li X, Lu P, Li B, Zhang W, Yang R, Chu Y, Luo K. Interleukin 2 and interleukin 10 function synergistically to promote CD8+ T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer. Int J Biochem Cell Biol 2017;87:1-7. [PMID: 28274688 DOI: 10.1016/j.biocel.2017.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
8 Basu A, Ramamoorthi G, Albert G, Gallen C, Beyer A, Snyder C, Koski G, Disis ML, Czerniecki BJ, Kodumudi K. Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy. Front Immunol 2021;12:669474. [PMID: 34012451 DOI: 10.3389/fimmu.2021.669474] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nicodemus CF. Antibody-based immunotherapy of solid cancers: progress and possibilities. Immunotherapy 2015;7:923-39. [PMID: 26314410 DOI: 10.2217/imt.15.57] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
10 Roberts A, Bentley L, Tang T, Stewart F, Pallini C, Juvvanapudi J, Wallace GR, Cooper AJ, Scott A, Thickett D, Lugg ST, Bancroft H, Hemming B, Ferris C, Langman G, Robinson A, Chapman J, Naidu B, Pinkney T, Taylor GS, Brock K, Stamataki Z, Brady CA, Curnow SJ, Gordon J, Qureshi O, Barnes NM. Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation. Sci Rep 2021;11:4030. [PMID: 33597595 DOI: 10.1038/s41598-021-83612-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pires BRB, Silva RCMC, Ferreira GM, Abdelhay E. NF-kappaB: Two Sides of the Same Coin. Genes (Basel) 2018;9:E24. [PMID: 29315242 DOI: 10.3390/genes9010024] [Cited by in Crossref: 95] [Cited by in F6Publishing: 73] [Article Influence: 31.7] [Reference Citation Analysis]
12 Zhong L, Zhang Y, Li M, Song Y, Liu D, Yang X, Yang D, Qu H, Lai L, Wang Q, Chen Z. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc. Aging (Albany NY) 2020;12:24394-423. [PMID: 33260160 DOI: 10.18632/aging.202293] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hadad SE, Alsolami M, Aldahlawi A, Alrahimi J, Basingab F, Hassoubah S, Alothaid H. In vivo evidence: Repression of mucosal immune responses in mice with colon cancer following sustained administration of Streptococcus thermophiles. Saudi J Biol Sci 2021;28:4751-61. [PMID: 34354463 DOI: 10.1016/j.sjbs.2021.04.090] [Reference Citation Analysis]
14 Min B, Kim D, Feige MJ. IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer. Exp Mol Med 2021;53:823-34. [PMID: 34045653 DOI: 10.1038/s12276-021-00630-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ramachandran S, Verma AK, Dev K, Goyal Y, Bhatt D, Alsahli MA, Rahmani AH, Almatroudi A, Almatroodi SA, Alrumaihi F, Khan NA. Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation. Oxid Med Cell Longev 2021;2021:5563746. [PMID: 34336101 DOI: 10.1155/2021/5563746] [Reference Citation Analysis]
16 Lacher MD, Bauer G, Fury B, Graeve S, Fledderman EL, Petrie TD, Coleal-Bergum DP, Hackett T, Perotti NH, Kong YY, Kwok WW, Wagner JP, Wiseman CL, Williams WV. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. Front Immunol 2018;9:776. [PMID: 29867922 DOI: 10.3389/fimmu.2018.00776] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
17 Chen N, Xu Y, Mou J, Rao Q, Xing H, Tian Z, Tang K, Wang M, Wang J. Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood Cancer J 2021;11:144. [PMID: 34392305 DOI: 10.1038/s41408-021-00536-x] [Reference Citation Analysis]
18 Hong P, Feng WY, Fu LH, Jin J, Fu JP. Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis. Cancer Biol Ther 2020;21:372-8. [PMID: 31910710 DOI: 10.1080/15384047.2019.1702404] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Islam H, Chamberlain TC, Mui AL, Little JP. Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol 2021;12:677008. [PMID: 34234779 DOI: 10.3389/fimmu.2021.677008] [Reference Citation Analysis]
20 Mir H, Singh S. CCL25 Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2021;1302:99-111. [PMID: 34286444 DOI: 10.1007/978-3-030-62658-7_8] [Reference Citation Analysis]
21 Kochenderfer JN, Somerville RPT, Lu T, Shi V, Bot A, Rossi J, Xue A, Goff SL, Yang JC, Sherry RM, Klebanoff CA, Kammula US, Sherman M, Perez A, Yuan CM, Feldman T, Friedberg JW, Roschewski MJ, Feldman SA, McIntyre L, Toomey MA, Rosenberg SA. Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. J Clin Oncol 2017;35:1803-13. [PMID: 28291388 DOI: 10.1200/JCO.2016.71.3024] [Cited by in Crossref: 281] [Cited by in F6Publishing: 155] [Article Influence: 70.3] [Reference Citation Analysis]
22 Wu Y, Liu Y, Dong Y, Vadgama J. Diabetes-associated dysregulated cytokines and cancer. Integr Cancer Sci Ther 2016;3:370-8. [PMID: 29930868 DOI: 10.15761/ICST.1000173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Huang SH, McCann CD, Mota TM, Wang C, Lipkin SM, Jones RB. Have Cells Harboring the HIV Reservoir Been Immunoedited? Front Immunol 2019;10:1842. [PMID: 31447850 DOI: 10.3389/fimmu.2019.01842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
24 Tan Y, Wang M, Zhang Y, Ge S, Zhong F, Xia G, Sun C. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy. Front Oncol 2021;11:693517. [PMID: 34178692 DOI: 10.3389/fonc.2021.693517] [Reference Citation Analysis]
25 Focaccetti C, Izzi V, Benvenuto M, Fazi S, Ciuffa S, Giganti MG, Potenza V, Manzari V, Modesti A, Bei R. Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes? Int J Mol Sci 2019;20:E1714. [PMID: 30959898 DOI: 10.3390/ijms20071714] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
26 Dennis KL, Saadalla A, Blatner NR, Wang S, Venkateswaran V, Gounari F, Cheroutre H, Weaver CT, Roers A, Egilmez NK, Khazaie K. T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine. Cancer Immunol Res 2015;3:806-14. [PMID: 25855122 DOI: 10.1158/2326-6066.CIR-14-0169] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
27 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Kusano T, Ehirchiou D, Matsumura T, Chobaz V, Nasi S, Castelblanco M, So A, Lavanchy C, Acha-Orbea H, Nishino T, Okamoto K, Busso N. Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth. Nat Commun 2019;10:4904. [PMID: 31659168 DOI: 10.1038/s41467-019-12565-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
29 Xue W, Zhang M. Updating targets for natural killer/T-cell lymphoma immunotherapy. Cancer Biol Med 2021;18:52-62. [PMID: 33628584 DOI: 10.20892/j.issn.2095-3941.2020.0400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Gundamaraju R, Vemuri R, Chong WC, Myers S, Norouzi S, Shastri MD, Eri R. Interplay between Endoplasmic Reticular Stress and Survivin in Colonic Epithelial Cells. Cells 2018;7:E171. [PMID: 30326660 DOI: 10.3390/cells7100171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Nistor GI, Dillman RO. Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial. J Transl Med 2020;18:176. [PMID: 32316978 DOI: 10.1186/s12967-020-02328-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 LeVan TD, Romberger DJ, Siahpush M, Grimm BL, Ramos AK, Johansson PL, Michaud TL, Heires AJ, Wyatt TA, Poole JA. Relationship of systemic IL-10 levels with proinflammatory cytokine responsiveness and lung function in agriculture workers. Respir Res 2018;19:166. [PMID: 30176916 DOI: 10.1186/s12931-018-0875-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Marshall EA, Ng KW, Kung SH, Conway EM, Martinez VD, Halvorsen EC, Rowbotham DA, Vucic EA, Plumb AW, Becker-Santos DD, Enfield KS, Kennett JY, Bennewith KL, Lockwood WW, Lam S, English JC, Abraham N, Lam WL. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Mol Cancer 2016;15:67. [PMID: 27784305 DOI: 10.1186/s12943-016-0551-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 13.8] [Reference Citation Analysis]
34 Naing A, Infante JR, Papadopoulos KP, Chan IH, Shen C, Ratti NP, Rojo B, Autio KA, Wong DJ, Patel MR, Ott PA, Falchook GS, Pant S, Hung A, Pekarek KL, Wu V, Adamow M, McCauley S, Mumm JB, Wong P, Van Vlasselaer P, Leveque J, Tannir NM, Oft M. PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients. Cancer Cell 2018;34:775-791.e3. [PMID: 30423297 DOI: 10.1016/j.ccell.2018.10.007] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 38.5] [Reference Citation Analysis]
35 Dianzani C, Monge C, Miglio G, Serpe L, Martina K, Cangemi L, Ferraris C, Mioletti S, Osella S, Gigliotti CL, Boggio E, Clemente N, Dianzani U, Battaglia L. Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment. Cancers (Basel) 2020;12:E1198. [PMID: 32397484 DOI: 10.3390/cancers12051198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Oft M. Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience. Semin Immunol 2019;44:101325. [PMID: 31706853 DOI: 10.1016/j.smim.2019.101325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
37 D'Alincourt Salazar M, Manuel ER, Tsai W, D'Apuzzo M, Goldstein L, Blazar BR, Diamond DJ. Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer. Oncoimmunology 2016;5:e1160184. [PMID: 27471630 DOI: 10.1080/2162402X.2016.1160184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
38 Gong SS, Li YX, Zhang MT, Du J, Ma PS, Yao WX, Zhou R, Niu Y, Sun T, Yu JQ. Neuroprotective Effect of Matrine in Mouse Model of Vincristine-Induced Neuropathic Pain. Neurochem Res 2016;41:3147-59. [PMID: 27561290 DOI: 10.1007/s11064-016-2040-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
39 Castillo-Rodríguez E, Pizarro-Sánchez S, Sanz AB, Ramos AM, Sanchez-Niño MD, Martin-Cleary C, Fernandez-Fernandez B, Ortiz A. Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son". Toxins (Basel) 2017;9:E114. [PMID: 28333114 DOI: 10.3390/toxins9040114] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
40 Barua A, Choudhury P, Mandal S, Panda CK, Saha P. Anti-Metastatic Potential of a Novel Xanthone Sourced by Swertia chirata Against In Vivo and In Vitro Breast Adenocarcinoma Frameworks. Asian Pac J Cancer Prev 2020;21:2865-75. [PMID: 33112542 DOI: 10.31557/APJCP.2020.21.10.2865] [Reference Citation Analysis]
41 Gorby C, Sotolongo Bellón J, Wilmes S, Warda W, Pohler E, Fyfe PK, Cozzani A, Ferrand C, Walter MR, Mitra S, Piehler J, Moraga I. Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Sci Signal 2020;13:eabc0653. [PMID: 32934073 DOI: 10.1126/scisignal.abc0653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
42 Andreicuț AD, Fischer-Fodor E, Pârvu AE, Ţigu AB, Cenariu M, Pârvu M, Cătoi FA, Irimie A. Antitumoral and Immunomodulatory Effect of Mahonia aquifolium Extracts. Oxid Med Cell Longev 2019;2019:6439021. [PMID: 31949880 DOI: 10.1155/2019/6439021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Meier T, Timm M, Montani M, Wilkens L. Gene networks and transcriptional regulators associated with liver cancer development and progression. BMC Med Genomics 2021;14:41. [PMID: 33541355 DOI: 10.1186/s12920-021-00883-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Bornstein S, Schmidt M, Choonoo G, Levin T, Gray J, Thomas CR Jr, Wong M, McWeeney S. IL-10 and integrin signaling pathways are associated with head and neck cancer progression. BMC Genomics 2016;17:38. [PMID: 26747525 DOI: 10.1186/s12864-015-2359-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
45 Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887-904. [PMID: 30361552 DOI: 10.1038/nrd.2018.169] [Cited by in Crossref: 427] [Cited by in F6Publishing: 359] [Article Influence: 142.3] [Reference Citation Analysis]
46 Ibrahim ML, Klement JD, Lu C, Redd PS, Xiao W, Yang D, Browning DD, Savage NM, Buckhaults PJ, Morse HC 3rd, Liu K. Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis. Cell Rep 2018;25:3036-3046.e6. [PMID: 30540937 DOI: 10.1016/j.celrep.2018.11.050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
47 Owen KL, Brockwell NK, Parker BS. JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers (Basel) 2019;11:E2002. [PMID: 31842362 DOI: 10.3390/cancers11122002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 35.5] [Reference Citation Analysis]
48 Hijaze N, Ledersnaider M, Simanovich E, Kassem S, Rahat MA. Inducing regulated necrosis and shifting macrophage polarization with anti-EMMPRIN antibody (161-pAb) and complement factors. J Leukoc Biol 2021;110:343-56. [PMID: 33205451 DOI: 10.1002/JLB.3A0520-333R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Szebeni GJ, Vizler C, Nagy LI, Kitajka K, Puskas LG. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets. Int J Mol Sci 2016;17:E1958. [PMID: 27886105 DOI: 10.3390/ijms17111958] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
50 Grzywa TM, Justyniarska M, Nowis D, Golab J. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development. Cancers (Basel) 2021;13:870. [PMID: 33669537 DOI: 10.3390/cancers13040870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Rivas JR, Liu Y, Alhakeem SS, Eckenrode JM, Marti F, Collard JP, Zhang Y, Shaaban KA, Muthusamy N, Hildebrandt GC, Fleischman RA, Chen L, Thorson JS, Leggas M, Bondada S. Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia. Leukemia 2021. [PMID: 33731852 DOI: 10.1038/s41375-021-01217-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhang L, Liu Y, Zheng HJ, Zhang CP. The Oral Microbiota May Have Influence on Oral Cancer. Front Cell Infect Microbiol 2019;9:476. [PMID: 32010645 DOI: 10.3389/fcimb.2019.00476] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 42.0] [Reference Citation Analysis]
53 Chen Q, Chen R, Dong Y. Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models. World J Surg Oncol 2020;18:165. [PMID: 32669133 DOI: 10.1186/s12957-020-01937-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Kwaśniak K, Czarnik-Kwaśniak J, Maziarz A, Aebisher D, Zielińska K, Karczmarek-Borowska B, Tabarkiewicz J. Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells. Cent Eur J Immunol 2019;44:190-200. [PMID: 31530989 DOI: 10.5114/ceji.2018.76273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
55 Atoum MF. ACC interleukin-10 gene promoter haplotype as a breast cancer risk factor predictor among Jordanian females. Onco Targets Ther 2016;9:3353-7. [PMID: 27330315 DOI: 10.2147/OTT.S101628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
56 Ritter B, Greten FR. Modulating inflammation for cancer therapy. J Exp Med 2019;216:1234-43. [PMID: 31023715 DOI: 10.1084/jem.20181739] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 21.0] [Reference Citation Analysis]
57 Yu Z, Zhao H, Feng X, Li H, Qiu C, Yi X, Tang H, Zhang J. Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells. Mol Ther Nucleic Acids. 2019;17:516-529. [PMID: 31351327 DOI: 10.1016/j.omtn.2019.05.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
58 Gornati L, Zanoni I, Granucci F. Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines. Front Immunol 2018;9:1484. [PMID: 29997628 DOI: 10.3389/fimmu.2018.01484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
59 Perng P, Lim M. Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites. Front Oncol 2015;5:153. [PMID: 26217588 DOI: 10.3389/fonc.2015.00153] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 13.5] [Reference Citation Analysis]
60 Boshtam M, Asgary S, Kouhpayeh S, Shariati L, Khanahmad H. Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review. Inflammation 2017;40:340-9. [PMID: 27878687 DOI: 10.1007/s10753-016-0477-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
61 Ma J, Kavelaars A, Dougherty PM, Heijnen CJ. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source. Cancer 2018;124:2289-98. [PMID: 29461625 DOI: 10.1002/cncr.31248] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 18.3] [Reference Citation Analysis]
62 Mengel J, Cardillo F, Pontes-de-Carvalho L. Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment. Front Microbiol 2016;7:675. [PMID: 27242702 DOI: 10.3389/fmicb.2016.00675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
63 Naing A, Papadopoulos KP, Autio KA, Ott PA, Patel MR, Wong DJ, Falchook GS, Pant S, Whiteside M, Rasco DR, Mumm JB, Chan IH, Bendell JC, Bauer TM, Colen RR, Hong DS, Van Vlasselaer P, Tannir NM, Oft M, Infante JR. Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. J Clin Oncol 2016;34:3562-9. [PMID: 27528724 DOI: 10.1200/JCO.2016.68.1106] [Cited by in Crossref: 101] [Cited by in F6Publishing: 52] [Article Influence: 25.3] [Reference Citation Analysis]
64 Haro MA, Dyevoich AM, Phipps JP, Haas KM. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity. Cancer Res 2019;79:159-70. [PMID: 30224373 DOI: 10.1158/0008-5472.CAN-18-0981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
65 Dillman RO, Nistor GI, Poole AJ. Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine. Hum Vaccin Immunother 2020;16:742-55. [PMID: 31625825 DOI: 10.1080/21645515.2019.1680239] [Reference Citation Analysis]